VC Outlook 2012
Start the new year off with SDVG! Join National Venture Capital Association President Mark Heesen, Frazier Healthcare's Dr. James Topper, and Sigma Partners' Pete Solvik as they tell you what is in store for the Venture World in 2012.
Dr. Topper joined Frazier Healthcare in 2003 and led multiple biopharma investments including Calistoga Pharmaceuticals that was acquired by Gilead in April 2011, Alnara Pharmaceuticals that was acquired by Eli Lilly, and more.
Pete Solvik has more than 20 years of experience on leadership teams of successful, high-growth information technology companies. He joined Sigma in 2002 and invests across the entire spectrum of information technology products and services.
Registration closed 1/23/12 at 10:00AM.
Walk-Ins Welcome: $60 pay at the door
Thanks to our sponsors: